Coastal Financial Corporation And 4 Other Stocks Have High Sales Growth And An Above 3% Return on Equity

(VIANEWS) – Coastal Financial Corporation (CCB), CNA Financial Corporation (CNA), AAON (AAON) are the highest sales growth and return on equity stocks on this list.

Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?

1. Coastal Financial Corporation (CCB)

89.9% sales growth and 20.05% return on equity

Coastal Financial Corporation operates as the bank holding company for Coastal Community Bank that provides various banking products and services to small to medium-sized businesses, professionals, and individuals in the Puget Sound region in Washington. It accepts a range of deposit products, including demand and savings accounts, time deposits, and money market accounts. The company also offers commercial and industrial loans, such as term loans, small business administration loans, commercial lines of credit, capital call lines working capital loans, equipment financing, borrowing base loans, and other loan products; owner-occupied and non-owner-occupied real estate loans, and multi-family residential loans; construction and land development loans; residential real estate loans; and consumer and other loans, including automobile, boat and recreational vehicle, and secured term loans, as well as overdraft protection. In addition, it provides remote deposit capture, online and mobile banking, and direct and reciprocal deposit services, as well as debit cards. Further, the company offers business accounts and cash management services, including business checking and savings accounts, and treasury services, as well as banking as a service, a platform that allows broker dealers and digital financial service providers to offer their customers banking services. Coastal Financial Corporation was founded in 1997 and is headquartered in Everett, Washington.

Earnings Per Share

As for profitability, Coastal Financial Corporation has a trailing twelve months EPS of $3.63.

PE Ratio

Coastal Financial Corporation has a trailing twelve months price to earnings ratio of 12.2. Meaning, the purchaser of the share is investing $12.2 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 20.05%.

Moving Average

Coastal Financial Corporation’s value is way higher than its 50-day moving average of $37.86 and higher than its 200-day moving average of $41.64.

Volume

Today’s last reported volume for Coastal Financial Corporation is 41382 which is 19.24% below its average volume of 51243.

Sales Growth

Coastal Financial Corporation’s sales growth is 89.8% for the present quarter and 89.9% for the next.

2. CNA Financial Corporation (CNA)

48.2% sales growth and 9.2% return on equity

CNA Financial Corporation provides commercial property and casualty insurance products primarily in the United States. It operates through Specialty, Commercial, International, Life & Group, and Corporate & Other segments. The company offers professional liability coverages and risk management services to various professional firms, including architects, real estate agents, and accounting and law firms; directors and officers, employment practices, fiduciary, and fidelity coverages to small and mid-size firms, public and privately held firms, and not-for-profit organizations; professional and general liability, as well as associated standard property and casualty coverages for healthcare industry; surety and fidelity bonds; and warranty and alternative risks products. It also provides property insurance products, such as property, marine, boiler, and machinery coverages; casualty insurance products comprising workers' compensation, general and product liability, commercial auto, and umbrella coverages; specialized loss-sensitive insurance programs and total risk management services; and run-off long term care policies. In addition, the company offers long-tail exposures comprising commercial automobile liability, workers compensation, general and medical professional liability, other professional and management liability, and assumed reinsurance run-off and products liability; and short-tail exposures, such as property, commercial automobile physical damage, marine, surety, and warranty. It markets its products through independent agents, brokers, and general underwriters to small, medium, and large businesses; insurance companies; associations; professionals; and other groups in the marine, oil and gas, construction, manufacturing, life science, property, financial services, healthcare, and technology industries. The company was founded in 1853 and is headquartered in Chicago, Illinois. CNA Financial Corporation operates as a subsidiary of Loews Corporation.

Earnings Per Share

As for profitability, CNA Financial Corporation has a trailing twelve months EPS of $3.29.

PE Ratio

CNA Financial Corporation has a trailing twelve months price to earnings ratio of 11.63. Meaning, the purchaser of the share is investing $11.63 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 9.2%.

Sales Growth

CNA Financial Corporation’s sales growth is 51.4% for the current quarter and 48.2% for the next.

Growth Estimates Quarters

The company’s growth estimates for the ongoing quarter and the next is 32.2% and 28.2%, respectively.

Revenue Growth

Year-on-year quarterly revenue growth grew by 9.3%, now sitting on 12.15B for the twelve trailing months.

Volume

Today’s last reported volume for CNA Financial Corporation is 108235 which is 38.31% below its average volume of 175467.

3. AAON (AAON)

29.9% sales growth and 21.87% return on equity

AAON, Inc., together with its subsidiaries, engages in engineering, manufacturing, marketing, and selling air conditioning and heating equipment in the United States and Canada. The company operates through three segments: AAON Oklahoma, AAON Coil Products, and BasX. It offers rooftop units, data center cooling solutions, cleanroom systems, chillers, packaged outdoor mechanical rooms, air handling units, makeup air units, energy recovery units, condensing units, geothermal/water-source heat pumps, coils, and controls. The company markets and sells its products to retail, manufacturing, educational, lodging, supermarket, data centers, medical and pharmaceutical, and other commercial industries. It sells its products through a network of independent manufacturer representative organizations and internal sales force. The company was incorporated in 1987 and is based in Tulsa, Oklahoma.

Earnings Per Share

As for profitability, AAON has a trailing twelve months EPS of $2.21.

PE Ratio

AAON has a trailing twelve months price to earnings ratio of 45. Meaning, the purchaser of the share is investing $45 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 21.87%.

Moving Average

AAON’s worth is higher than its 50-day moving average of $94.31 and way above its 200-day moving average of $82.43.

Volume

Today’s last reported volume for AAON is 231418 which is 26.27% below its average volume of 313908.

4. Incyte Corporation (INCY)

14.4% sales growth and 7.79% return on equity

Incyte Corporation, a biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutics for hematology/oncology, and inflammation and autoimmunity areas in the United States, Europe, Japan, and internationally. The company offers JAKAFI (ruxolitinib), for the treatment of adults with intermediate or high-risk myelofibrosis; MONJUVI (tafasitamab-cxix)/MINJUVI (tafasitamab), for the treatment of adult patients with relapsed or refractory diffuse large B-cell lymphoma; PEMAZYRE (pemigatinib), a fibroblast growth factor receptor kinase inhibitor that act as oncogenic drivers in various liquid and solid tumor types; and ICLUSIG, a kinase inhibitor to treat chronic myeloid leukemia and philadelphia-chromosome positive acute lymphoblastic leukemia. Its clinical stage products include axatilimab, an anti-CSF-1R monoclonal antibody being developed as a therapy for patients with chronic GVHD as well as in additional immune-mediated diseases; and parsaclisib, a PI3Kd inhibitor which is in Phase II clinical trial for follicular lymphoma, marginal zone lymphoma, and mantel cell lymphoma. It also develops retifanlimab, is in Phase III clinical trials for squamous cell carcinoma of the anal canal and non-small cell lung cancer, and Fast Track designation for the treatment of metastatic MSI-H or DNA mismatch repair (dMMR) endometrial cancer; and INCB99280 and INCB99318 currently under Phase I for the treatment solid tumors. It has collaboration out- license agreements with Novartis, Lilly, Innovent, InnoCare, Maruho, and CMS Aesthetics Limited; and in- license agreements with Agenus, Merus, MacroGenics, Syros, MorphoSys, and Syndax. The company was incorporated in 1991 and is headquartered in Wilmington, Delaware.

Earnings Per Share

As for profitability, Incyte Corporation has a trailing twelve months EPS of $1.43.

PE Ratio

Incyte Corporation has a trailing twelve months price to earnings ratio of 44.7. Meaning, the purchaser of the share is investing $44.7 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 7.79%.

Volume

Today’s last reported volume for Incyte Corporation is 673289 which is 65.56% below its average volume of 1955440.

Growth Estimates Quarters

The company’s growth estimates for the current quarter is a negative 16.8% and positive 70% for the next.

Revenue Growth

Year-on-year quarterly revenue growth grew by 10.3%, now sitting on 3.47B for the twelve trailing months.

5. OFG Bancorp (OFG)

10.4% sales growth and 16.43% return on equity

OFG Bancorp, a financial holding company, provides various banking and financial services. It operates in three segments: Banking, Wealth Management, and Treasury. The company offers checking and savings accounts, as well as time deposit products; commercial, consumer, auto, and mortgage lending; financial planning; and corporate and individual trust services. It also provides securities brokerage services, including various investment alternatives, such as tax-advantaged fixed income securities, mutual funds, stocks, and bonds to retail and institutional clients; separately-managed accounts and mutual fund asset allocation programs; and pension administration, trust, and other financial services. In addition, the company involves in insurance agency business; administration of retirement plans; various treasury-related functions with an investment portfolio consisting of mortgage-backed securities, obligations of U.S. government sponsored agencies, and money market instruments; and management and participation in public offerings and private placements of debt and equity securities. Further, it offers investment brokerage, investment banking, and money and interest rate risk management, as well as derivatives and borrowings activities. The company operates through a network of 55 branches in Puerto Rico and 2 branches in USVI. OFG Bancorp was founded in 1964 and is based in San Juan, Puerto Rico.

Earnings Per Share

As for profitability, OFG Bancorp has a trailing twelve months EPS of $3.64.

PE Ratio

OFG Bancorp has a trailing twelve months price to earnings ratio of 7.8. Meaning, the purchaser of the share is investing $7.8 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 16.43%.

Moving Average

OFG Bancorp’s worth is way higher than its 50-day moving average of $25.59 and higher than its 200-day moving average of $26.82.

Dividend Yield

As claimed by Morningstar, Inc., the next dividend payment is on Jun 28, 2023, the estimated forward annual dividend rate is 0.88 and the estimated forward annual dividend yield is 3.12%.

Yearly Top and Bottom Value

OFG Bancorp’s stock is valued at $28.41 at 20:22 EST, below its 52-week high of $30.52 and way above its 52-week low of $22.34.

Previous days news about OFG Bancorp(OFG)

  • According to Zacks on Monday, 24 July, "Those include Zacks Rank #1 (Strong Buy) stocks LCNB ((LCNB Quick QuoteLCNB – Free Report) ) and OFG Bancorp ((OFG Quick QuoteOFG – Free Report) )."
  • Are you looking for a top momentum pick? why OFG bancorp (ofg) is a great choice. According to Zacks on Tuesday, 25 July, "Over the past quarter, shares of OFG Bancorp have risen 34.69%, and are up 25.44% in the last year. ", "Below, we take a look at OFG Bancorp (OFG Quick QuoteOFG – Free Report) , a company that currently holds a Momentum Style Score of A. We also talk about price change and earnings estimate revisions, two of the main aspects of the Momentum Style Score."

Leave a Reply

Your email address will not be published. Required fields are marked *